Last reviewed · How we verify

NCT05576311

Codesign of an Optical Device to Measure Urine Flow and Volume

Status unknown Last updated 12 October 2022
What this trial tests

trial testing Focus Group in Urinary Incontinence in 45 participants. Status unknown.

Timeline
1 November 2022
Primary endpoint
31 December 2022
28 February 2023

Quick facts

Lead sponsorTeesside University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment45
Start date1 November 2022
Primary completion31 December 2022
Estimated completion28 February 2023

Drugs / interventions tested

Conditions studied

Sponsor

Teesside University

Who can join

18 and older, any sex, with Urinary Incontinence or Urinary Retention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is seeking to understand the needs of patients and healthcare practitioners for an innovation in the way that changes in bladder function are assessed. This information will be used in the design and evaluation of a device, being developed in parallel, that assesses changes to the volume and flow of urine in order to determine changes in bladder function. In order to ensure development is optimal, the principal research objective is therefore to understand the needs of patients and healthcare practitioners (ranging from care home staff and GPs in primary care, to urologists in tertiary referral centres).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Focus Group

Trials testing the same drug.

Other recruiting trials for Urinary Incontinence

Currently open trials in the same condition.

Other Teesside University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05576311.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing